Novartis MS Drug Kesimpta Quick Out Of The Blocks

Strong Challenger To Roche's Ocrevus

 
• By Kevin Grogan
Starting_Block
Rapid start for Kesimpta in the US • Source: Shutterstock

More from Neurological

More from Therapeutic Category